MacroGenics
MGNX
#8495
Rank
$0.22 B
Marketcap
$3.47
Share price
-3.61%
Change (1 day)
173.23%
Change (1 year)

MacroGenics (MGNX) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : $0.20 Billion USD

According to MacroGenics's latest financial reports the company's total liabilities are $0.20 Billion USD. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

MacroGenics - Total liabilities on balance sheet (from 2012 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31$0.14 B-0.14%
2023-12-31$0.14 B5.31%
2022-12-31$0.13 B44.79%
2021-12-31$95.62 M15.41%
2020-12-31$82.85 M1.2%
2019-12-31$81.87 M-8.27%
2018-12-31$89.25 M19.57%
2017-12-31$74.64 M75.59%
2016-12-31$42.51 M-7.45%
2015-12-31$45.93 M-12.68%
2014-12-31$52.6 M12.23%
2013-12-31$46.86 M-24.39%
2012-12-31$61.98 M-22.68%
2011-12-31$80.16 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Pfizer
PFE
$121.38 B 59,471.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
$85.94 B 42,077.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
$81.92 B 40,107.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
$36.40 B 17,766.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
$84.20 B 41,224.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
$71.53 B 35,005.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
$0.23 B 17.74%๐Ÿ‡บ๐Ÿ‡ธ USA